Belgravia Announces Effective Date of Share Consolidation

Toronto, Ontario, Oct. 22, 2026 (GLOBE NEWSWIRE) — Belgravia Hartford Capital Inc. (CSE: BLGV) (OTC: BLGVF) (FRA: ECA) (the “Corporation” or “Belgravia”) announces that further to its press release dated October 19, 2026, the consolidation of its issued and outstanding common shares (the “Shares“) on the basis of one new Share (a “Post-consolidated Share“) for […]

financialpost.com ·2h ago

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

Is IonQ a Millionaire-Maker Stock?

Key PointsIonQ's upcoming new product launch could create major business opportunities for it.

2h ago ·nasdaq.com

Northview Residential REIT Announces October Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Oct. 22, 2026 (GLOBE NEWSWIRE) — Northview Residential REIT (the “REIT”) today announced its…

2h ago ·financialpost.com

The S&P 500 Is Just Shy of a Record With 10 Weeks Left in the Year. Here's What History Says Could Happen Next.

Key PointsThe S&P 500 closed on Oct. 21 around 0.8% under its record close on Oct. 6.

2h ago ·nasdaq.com

Up 17% Off Its 52-Week Low, Is Nike's Turnaround Finally Gaining Steam?

The market is liking its progress after more than two years of serious declines.

Nike's stock price up 17% from 52-week low
Sales down 4% year-over-year in latest fiscal quarter
Growth in basketball, running, and global football divisions

2h ago ·fool.com

Stock Market Today, Oct. 22: SpaceX Earnings Beat Sparks Profit-Taking

Quarterly revenue jumped 161% and beat estimates, but a share unlock and profit-taking erased gains by close, today, Oct. 22, 2026.

SpaceX earnings report causes profit-taking among investors.
Shares closed at $144.75, marking a 9.14% decrease.
Trading volume reached 193.8 million shares, significantly higher than average.

2h ago ·fool.com

Stock Market Today, Oct. 22: Moderna Stock Plummets 18% on Melanoma Vaccine Data Leak Reports

Moderna (NASDAQ:MRNA), an mRNA medicines and preventive vaccine developer, closed at $202.63, down 17.57%. Reports of a possible leak of late-stage personalized melanoma vaccine data sent shares lower…

2h ago ·nasdaq.com